Shandong Weigao Group Medical Polymer Company Limited, along with its subsidiaries, is engaged in the research and development, production and sale of single-use medical devices. The Company operates in three segments: single use medical products segment, which engages in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets and blood bags; orthopaedic products segment, which engages in the production and sale of orthopaedic products, and blood purification products segment, which engages in the production and sale of blood purification products and related medical equipment. It has sales network and customer base of over 5,069 healthcare organizations, including 2,951 hospitals and 414 blood stations. On March 31, 2011, the Company disposed 90% of the equity interest in Shenyang Weigao Jinbao Trading Co., Ltd.